Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 08:47 am Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | The Vanguard Group | 77,558 5.380% | -28,905 (-27.15%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 111,766 7.800% | -11,969 (-9.67%) | Filing History |
| 2021-10-12 1:40 pm Sale | 2021-09-30 | 13G | Alaunos Therapeutics, Inc. TCRT | MILLER VALUE PARTNERS LLC | 25,253 1.730% | -83,108 (-76.70%) | Filing History |
| 2021-02-16 1:10 pm Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | Hardie Robert D. | 70,128 4.900% | 1,254 (+1.82%) | Filing History |
| 2021-02-16 10:05 am Sale | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MILLER VALUE PARTNERS LLC | 108,361 7.450% | -1,787 (-1.62%) | Filing History |
| 2021-02-10 12:04 pm Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | The Vanguard Group | 106,463 7.450% | 22,496 (+26.79%) | Filing History |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 123,736 8.700% | 40,457 (+48.58%) | Filing History |
| 2021-01-07 4:21 pm Purchase | 2020-12-28 | 13G | Alaunos Therapeutics, Inc. TCRT | Discovery Capital Management, LLC | 73,298 5.130% | 73,298 (New Position) | Filing History |